Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019

SELL
$6.59 - $11.28 $26,360 - $45,120
-4,000 Closed
0 $0
Q3 2018

Oct 29, 2018

BUY
$9.35 - $12.44 $15,315 - $20,376
1,638 Added 69.35%
4,000 $43,000
Q2 2018

Jul 18, 2018

BUY
$9.11 - $28.88 $21,517 - $68,214
2,362 New
2,362 $27,000

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0

About CATALYST BIOSCIENCES, INC.


  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.